-
FDA Application for Opicapone as Parkinson’s Add-on Therapy Accepted
The U.S. Food and Drug Administration has accepted Neurocrine Biosciences’ new drug application for opicapone as a potential add-on therapy for Parkinson’s. Read more here.
What do you think about this news?
Sorry, there were no replies found.
Log in to reply.